Clinical trial
Stereotactic Body Radiation Therapy in Treating Patients With Stage I or Stage…
NCT00471835 · Wake Forest University Health Sciences, Other · Withdrawn
Key facts
| NCT number | NCT00471835 |
|---|---|
| Title | Stereotactic Body Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer |
| Official title | A Phase I/II Study of Hypofractionated Stereotactic Body Radiotherapy for Stage I/II Non-small Cell Lung Cancer Within the Central Lung Region and the Prognostic Impact of FDG Positron Emission Tomography |
| Lead sponsor | Wake Forest University Health Sciences, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Withdrawn |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Procedure, Radiation |
| Interventions | computed tomography, positron emission tomography, stereotactic body radiation therapy |
| Enrollment | 0 |
| Start date | Jan 1, 2007 |
| First posted | May 10, 2007 |
| Last update posted | Jan 19, 2017 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: